BioNTech SE (22UA.F) FSX

92.05

+0.2(+0.22%)

Updated at October 21 01:13PM

Currency In EUR

Valuation

Market Cap26.13B
Enterprise Value16.62B
P/E Ratio-64.4
PEG Ratio-1.15
Price/Sales Ratio7.73
Price/Book Ratio1.21
Enterprise/Revenue4.26
Enterprise/EBITDA-53.87

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.12
Operating Margin-0.3

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.02

Income Statement

Revenue2.75B
Revenue/Share11.91
Gross Profit2.21B
EBITDA-367.1M
Net Income-665.3M
Diluted EPS-2.77

Balance Sheet

Total Cash14.04B
Total Cash/Share58.09
Total Debt269.6M
Total Debt/Equity0.01
Current Ratio8.61
Book Value Per Share76.59

Price History

52-Week Change-8.32
52-Week High124.6
52-Week Low71
Moving Average 50 Days88.83
Moving Average 200 Days94.64

Statistics

Average Volume1,631
Shares Outstanding240.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A